| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
3.16 -0.03 (-0.01%) |
10-17 16:00 |
|
Open: |
3.17 |
Pre close: |
3.19 |
Target:
|
3.97
|
|
High: |
3.17 |
Low: |
3.05 |
Resistance:
|
3.40
3.64
|
|
Volume: |
785,103 |
Market Cap: |
526M |
Support:
|
3.00
2.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.11
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
3.18  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
3.09 |
Stochastic Oscillator |
%K(14,3):
|
21.05 |
|
MA(250): |
3.55 |
%D(3): |
15.96 |
|
Average Volume(K) |
3-Month: |
263875
|
52-Week |
High:
|
4.71 |
|
10-Days: |
282847 |
Low: |
2.56 |
|
RSI |
RSI(14):
|
49.69 |
Change(%): |
-20.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.650 |
Return on Equity (ttm) |
-96.8 |
Shares Out. (M) |
166.44 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-82.5 |
Shares Float (M) |
165.87 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.07 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
93.90 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
16654 |
|
Book Value (p.s.) |
4.110 |
EBITDA (p.s.) |
-0.107 |
P/E |
-4.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.77 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-87.71 |
P/S |
26297520128.00 |
|
Operating Margin |
-3532.38 |
Levered Free Cash Flow
(M) |
-54.31 |
P/CF |
-6.00 |
|
|
|
|
|
|
